TITLE

Stem Cell Therapy and Regenerative Medicine

AUTHOR(S)
O'Brien, Timothy; Barry, P.
PUB. DATE
October 2009
SOURCE
Mayo Clinic Proceedings;Oct2009, Vol. 84 Issue 10, p859
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on the significance of stem cell therapy to address the clinical needs for cardiac repair and bone disorders. He relates to the two clinical studies conducted to patients with myocardial infraction (MI) in which the study of B. J. Gersch and colleagues has shown improvements on the left ventricular ejection fraction (LVEF) compared to the REGENT trial. The author supports the use of mesenchymal stem cells (MSCs) combined with regenerative medicine in treating bone disorders.
ACCESSION #
44748180

 

Related Articles

  • Potential feasibility of dental stem cells for regenerative therapies: stem cell transplantation and whole-tooth engineering. Nakahara, Taka // Odontology;Jul2011, Vol. 99 Issue 2, p105 

    Multipotent mesenchymal stem cells from bone marrow are expected to be a somatic stem cell source for the development of new cell-based therapy in regenerative medicine. However, dental clinicians are unlikely to carry out autologous cell/tissue collection from patients (i.e., marrow aspiration)...

  • Potential for Using Adult Stem Cells in Clinical Orthopaedics. Zachos, Teri A.; Smith, Thomas J.; Zelner, Eric; Smith // AAOS Now;Jan2012, Vol. 6 Issue 1, p42 

    The article presents an overview of the potentials of integrating adult stem cells in clinical orthopaedics in the U.S. It notes that the cell-based therapies have demonstrated great promise in vitro settings, however the results often do not correlate with their utility in vivo. It further...

  • CIRM Loan to Boost Diabetes Research. Chambers, Heather // San Diego Business Journal;11/9/2009, Vol. 30 Issue 45, p1 

    The article reports that the California Institute for Regenerative Medicine (CIRM), the distributor of the state fund worth 3 billion dollars for stem cell research, pledged for Novocell Inc., a stem cell engineering company, to boost diabetic research in San Diego, California. CIRM aims to loan...

  • Pluripotent stem cells in regenerative medicine: challenges and recent progress. Tabar, Viviane; Studer, Lorenz // Nature Reviews Genetics;Feb2014, Vol. 15 Issue 2, p82 

    After years of incremental progress, several recent studies have succeeded in deriving disease-relevant cell types from human pluripotent stem cell (hPSC) sources. The prospect of an unlimited cell source, combined with promising preclinical data, indicates that hPSC technology may be on the...

  • Florida company co-hosts stem cell conference in Havana. WERNER, JOHANNES // Cuba Standard Monthly;Oct2016, Vol. 24 Issue 9, p33 

    Information about the "First Inter American Stem Cell Conference" that was held in Palacio de Convenciones, Havana in Cuba from October 13-15, 2016 is presented. Topics discussed include regenerative medicine and cellular therapy for treating different illnesses, the conference hosted by the...

  • Tbx3: another important piece fitted into the pluripotent stem cell puzzle. Pirity, Melinda K.; Dinnyes, Andras // Stem Cell Research & Therapy; 

    Induced pluripotent stem cells (iPSCs) are novel tools for biomedical research, with a promise for future regenerative medicine applications. Recently, Han and colleagues reported in Nature that T box gene 3 (Tbx3) can improve the quality of mouse iPSCs and increase their germline transmission...

  • A Comparison of Stem Cells for Therapeutic Use. Rodgerson, Denis; Harris, Alan // Stem Cell Reviews & Reports;Dec2011, Vol. 7 Issue 4, p782 

    A critical comparison of the attributes of several types of stem cells is presented, with particular emphasis on properties that are critical for the application of these cells for therapeutic purposes. The importance of an autologous source of pluripotent stem cells is stressed. It is apparent...

  • Amniotic fluid stem cells: an ideal resource for therapeutic application in bone tissue engineering. PANTALONE, A.; ANTONUCCI, I.; GUELFI, M.; PANTALONE, P.; USUELLI, F. G.; STUPPIA, L.; SALINI, V. // European Review for Medical & Pharmacological Sciences;2016, Vol. 20 Issue 13, p2884 

    OBJECTIVE: Skeletal diseases, both degenerative and secondary to trauma, infections or tumors, represent an ideal target for regenerative medicine and in the last years, stem cells have been considered as good candidates for in vitro and in vivo bone regeneration. To date, several stem cell...

  • Understanding the application of stem cell therapy in cardiovascular diseases. Sharma, Rakesh K.; Voelker, Donald J.; Sharma, Roma; Reddy, Hanumanth K. // Stem Cells & Cloning: Advances & Applications;2012 Part 2, Vol. 5, p29 

    Throughout their lifetime, an individual may sustain many injuries and recover spontaneously over a period of time, without even realizing the injury in the first place. Wound healing occurs due to a proliferation of stem cells capable of restoring the injured tissue. The ability of adult stem...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics